Skip to main content

Crawford Raphael Goszcz's Form 4/A amendment

Amended

Albemarle CorpALB · filed Sep 7, 2022

Accession no.
0000915913-22-000143
Filed
Sep 7, 2022
Trade date
Aug 31, 2022
Filing delay
7 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Sep 1, 2022

This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.85M. It was filed 7 days after the trade.

This amendment replaces 0000915913-22-000139 (filed Sep 1, 2022).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Crawford Raphael GoszczCIK 0001776484Officer (President, Catalysts)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 31, 2022Common StockMOption exerciseAcquired+7,218$91.00+$656,83825,914Direct
Aug 31, 2022Common StockSSaleDisposed−7,218$268.28−$1,936,445.0418,696Direct
Aug 31, 2022Common StockSSaleDisposed−320$271.24−$86,796.818,376Direct
Aug 31, 2022Common StockSSaleDisposed−2,839$271.59F2−$771,044.0115,537Direct
Aug 31, 2022Common StockSSaleDisposed−7,591$270.20−$2,051,088.27,946Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 31, 2022Common StockMOption exerciseDisposed−7,218$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.05 to $269.65, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2

See remark below.

Referenced by the price of 1 transaction in Table I.

F3

On February 26, 2019, the reporting person was granted a 10-year option exercisable for 7,218 shares of Common Stock. The option cliff-vested on 2/26/2022.

Remarks

Form 4 amended to correct typographical error in sale price of 2,839 shares from $21.59 to $271.59.

Read the full filing on SEC EDGAR (opens in a new tab)